Understanding how the body produces a specific immune response to Candida infections
Control of Type I Interferon Production in Response to Candida albicans
['FUNDING_R01'] · MASSACHUSETTS GENERAL HOSPITAL · NIH-10814334
This study is looking at how our immune system fights off infections from a common fungus called Candida, especially in people with weakened immune systems, to find better ways to boost their defenses against these infections.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MASSACHUSETTS GENERAL HOSPITAL (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10814334 on ClinicalTrials.gov |
What this research studies
This research investigates the mechanisms by which the body produces type I interferons in response to infections caused by Candida albicans, a common fungal pathogen. It focuses on the role of specific immune cells, particularly plasmacytoid dendritic cells, in generating this immune response. By exploring the signaling pathways involved, the research aims to uncover how these processes can be regulated to improve defenses against invasive fungal infections, especially in immunocompromised patients. The findings could lead to new therapeutic strategies to enhance the immune response against Candida infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are immunocompromised patients who are at increased risk for invasive fungal infections, particularly those caused by Candida.
Not a fit: Patients with healthy immune systems or those not at risk for fungal infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients at high risk of severe fungal infections, potentially reducing mortality rates.
How similar studies have performed: Previous research has shown that understanding immune responses to pathogens can lead to significant advancements in treatment, suggesting that this approach has the potential for success.
Where this research is happening
BOSTON, UNITED STATES
- MASSACHUSETTS GENERAL HOSPITAL — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VYAS, JATIN M — MASSACHUSETTS GENERAL HOSPITAL
- Study coordinator: VYAS, JATIN M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.